Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia

One of the key features of acute myeloid leukemia (AML), a group of very aggressive myeloid malignancies, is their strikingly heterogenous outcomes. Accurate biomarkers are needed to improve prognostic assessment. Glutamate oxaloacetate transaminase 1 (GOT1) is essential for cell proliferation and a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Oncol
Egile Nagusiak: Cheng, Zhiheng, Dai, Yifeng, Zeng, Tiansheng, Liu, Yan, Cui, Longzhen, Qian, Tingting, Si, Chaozeng, Huang, Wenhui, Pang, Ying, Ye, Xu, Shi, Jinlong, Fu, Lin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7105742/
https://ncbi.nlm.nih.gov/pubmed/32266153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00379
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak